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III. Abstract 
 Drug resistant, invasive tumors are among the most devastating cancers. It is 
the goal of this project to explore the potential relationships between these two 
phenotypes in a variety of tissue culture model systems. Invadopodia are actin-rich 
protrusions of the cellular membrane involved in extracellular matrix remodeling that 
allow cancer cells to invade other tissues during metastasis. Organic anion 
transporting-polypeptides (OATPs) mediate xenobiotic exchange across the cellular 
membrane and are believed to colocalize with lipid raft domains (LRDs) and 
caveolin-1 in humans, two factors that are also required for invadopodia function in 
breast cancer and melanoma cells. These transporters are thought to contribute to 
the multi-drug resistance phenotype of stubborn tumors and are upregulated in 
multiple cancer cell lines.  
 To determine if functional OATPs are present in invadopodia-competent cells, 
fluorescence transport assays were performed on human prostate (PC3, LNCaP) 
and breast (MDA-MB-231) cancer cells as well as a murine fibroblast (NIH-3T3) cell 
line overexpressing constitutively active Src (Src-3T3). All cell lines exhibited robust 
uptake of rhodamine-123 (Rh-123), a fluorescent substrate of OATP1A2. 
Furthermore, the uptake of Rh-123 by MDA-MB-231 and PC3 cells was likely 
protein-mediated as the fluorescence signals were reduced by 67% and 68% 
respectively when the transport assays were performed on ice. In addition, an 
inhibition assay indicated that OATP1A2 might be responsible for the observed 
uptake of Rh-123 by LNCaP cells grown in androgen-depleted conditions. These 
inhibition studies are ongoing, and future experiments will explore the ultimate 
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downstream effects of OATP substrates on invadopodia morphology and function. If 
OATPs play a role in invadopodia activity, they may contribute to the enhanced 
invasive phenotype of certain cancers and therefore serve as viable therapeutic 
targets.  
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IV. Introduction 
 From the earliest stages of conception to the final moments of life, cellular 
motility plays an important role in the survival of many organisms. In addition, the 
ability of a cell to regulate its internal composition by importing nutrients and 
exporting wastes allows it to flourish and adapt to changing environmental 
conditions. Malignant tumor cells have to ability to manipulate these “normal” cellular 
mechanisms in order to metastasize and resist drug treatments respectively, which 
frequently results in poor patient outcomes. 
 Invadopodia are structural features of highly aggressive cancer cells that are 
believed to play important roles in tumor metastasis.1 These actin-dense, lipid-rich 
ventral protrusions of the cell membrane are known to exert motive forces on and 
mediate the remodeling of the extracellular matrix (ECM) (Figure 1). These 
processes allow a cancer cell to leave its native environment and invade other 
tissues during metastasis, a phenomenon that accounts for approximately 90% of 
cancer related deaths.2 
 Among the many proteins that regulate invadopodia activity, membrane type-
1 matrix metalloproteinase (MT1-MMP) is especially critical for ECM degradation 
and remodeling.3 MT1-MMP activity is regulated by caveolin-1 (Cav-1), an integral 
membrane protein that plays roles in endocytosis, signal transduction, vesicle 
transport, and migration.4 Both MT1-MMP and Cav-1 are concentrated at and 
trafficked through cholesterol-rich regions of the cellular membrane known as lipid 
rafts.5 Lipid rafts are membrane domains comprised of sphingolipids and proteins 
that exhibit some degree of segregation from the fluid phospholipid bilayer and are 
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believed to play important roles in signal transduction.6,7 Invadopodia are known to 
be enriched in lipid rafts and caveolin-1, which are critical for the formation and 
function of these structures in breast cancer and melanoma cells.5,8,9  
 
Figure 1. Invadopodia structure and function in murine fibroblasts 
overexpressing constitutively active Src. (A) Invadopodia are punctate cellular 
protrusions (green arrow) that form rosette superstructures (white arrow) in mature, 
aggressive cancer cells. Actin was stained with phalloidin 594 (red) and nuclei with 
DAPI (blue). (B) Gelatin degradation assays are used to score invadopodia activity. 
Black areas correspond to invadopodia-mediated matrix degradation. Coverslips 
were coated with Alexa Fluor 488-conjugated gelatin (green) to simulate extracellular 
matrix (ECM), and nuclei were stained with DAPI (blue). 
 
 Organic anion transporting polypeptides (OATPs) are 12-transmembrane 
glycoproteins that mediate the transfer of large hydrophobic organic anions across 
the cellular membrane (Figure 2).10 Conjugated sex steroids, bile acids, drugs, and 
toxins are among the many substances transported by these promiscuous proteins. 
OATPs and organic anion transporters (OATs), a homologous class of proteins, are 
thought to contribute to the multi-drug resistance phenotype of stubborn cancers.11 
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Figure 2. Fold recognition model of OATP1B1 and OAT1.10 OATPs and OATs are 
homologous proteins that contain 12 transmembrane helical domains. (A) OATP1B1 
and (B) OAT1 models were generated using Phyre, a protein homology recognition 
server. 
 
 Interestingly, OATs were found to colocalize with lipid raft domains and 
associate with caveolin-1 in human embryonic kidney cells.12 Because OATs (and 
thus OATPs) are believed to exist in cellular environments consistent with those of 
invadopodia, we hypothesized that these transporters may be localized to and thus 
play a role in the formation and/or function of invadopodia. While the assumption 
that OATs and OATPs colocalize to similar regions of the cell may be true for some 
transporters, it should be noted that there is evidence that at least one OATP 
isoform (1B1) may not require lipid rafts for proper functioning.13 This indicates that 
OATP expression at invadopodia may be isoform-specific. 
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  Arawaka and coworkers observed that the OATP isoform 1A2 was 
upregulated in androgen receptor-positive (AR-positive) LNCaP prostate cancer 
cells grown in androgen-depleted conditions, which indicated a potential connection 
between the functions of OATPs and invadopodia.14 LNCaP cells subjected to 
androgen-depleted conditions are studied as a model of prostate cancer in the 
process of becoming androgen-resistant. This period of transition is of great 
significance to researchers because androgen-insensitive prostate cancer is 
essentially untreatable since it no longer responds to androgen deprivation therapy 
(ADT, i.e. castration) and is generally more aggressive than its androgen-dependent 
forms.14,15 OATP1A2 is known to transport dehydroepiandrosterone sulfate 
(DHEAS), an inactive androgen precursor produced by the adrenal glands, into 
prostate cells. DHEAS is eventually converted to androstenedione, a compound that 
activates the androgen receptor (AR), which in turn promotes cell growth and motility 
via genomic and extranuclear mechanisms.14,16 
 Since serum DHEAS concentration remains high after castration, Arakawa et 
al. suggested the upregulation of OATP1A2 may provide prostate cancer cells with a 
means to acquire alternative androgen precursors from the serum.14 Thus 
OATP1A2-mediated transport of these precursors may contribute to the stimulation 
of the androgen receptor, which could promote the survival of the cancer during this 
period of transition. 
 The effects of androgen receptor stimulation on invadopodia morphology and 
activity have not yet been explored, but previous reports have indicated a number of 
interesting potential relationships (see Figure 3). For example, AR stimulation in 
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NIH-3T3 cells by a synthetic agonist, R1881 (methyltrienolone), increased cellular 
motility and induced the rapid formation of cytoskeletal ruffles and protrusions.16 
Other studies have implicated the activities of AR in pathways known to promote the 
formation of invadopodia. Src tyrosine kinase, the first discovered oncogene, is 
known to associate with and phosphorylate the androgen receptor in castration-
resistant cancers and its upregulation has been shown to promote the formation of 
invadopodia in NIH-3T3 cells.17,18 Furthermore, recent evidence has indicated that 
Src is not only upregulated in the LNCaP-derived castration-resistant prostate 
cancer cell line C4-2, but may actually serve to activate the AR in the absence of 
gonadal androgens.19  
 Additionally, AR stimulation has been shown to activate but not upregulate 
Src in PC3 cells overexpressing AR while inducing the formation of filopodial 
structures and promoting Boyden chamber migration (a measure of cell invasion).20 
Similar effects on LNCaP and C4-2 migration in response to AR stimulation were 
observed. While the R1881-induced increases in cellular motility and cytoskeletal 
rearrangements reported by Castoria et al. were believed to occur via a Src-
independent pathway, it is possible that AR-activated Src may additively contribute 
to the formation and/or activity of invadopodia in aggressive cancer cells.16 Given the 
crosstalk between Src, a known invadopodia promoter, and AR, a protein putatively 
activated by OATP1A2 substrates, future experiments will explore the role of 
androgens in invadopodia development. A proposed mechanism for OATP-AR-Src 
mediated invadopodia enhancement that combines the results of the 
aforementioned studies is described in Figure 3. 
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Figure 3. Proposed mechanism for OATP-AR-Src signaling in invadopodia 
formation and function. First, androgen precursor molecules like DHEAS are 
transported into the cell via OATP1A2 in the absence of gonadal androgens. Next, 
activation of the precursor molecules occurs intracellularly via cleavage and 
processing reactions. Stimulation of AR by these processed androgens activates 
Src, which in turn activates a variety of molecules required for invadopodia 
development and activity. OATP1A2 is localized to lipid rafts (not shown), which are 
concentrated in the single invadopod depicted (bulge). 
 
 These previous reports suggest that OATs (and thus OATPs) may be 
localized to invadopodia and transport substances known to promote cellular motility 
and cytoskeletal remodeling via AR activation. It is the purpose of this project to 
identify and elucidate potential interactions between OATPs, their substrates, and 
invadopodia in a variety of cell culture models. Fluorescence transport assays were 
employed using OATP substrates and inhibitors to determine the presence and 
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identities of OATPs in multiple cancer cell lines. Human prostate (PC3, LNCaP) and 
breast (MDA-MD-231) cancer cells as well as a murine fibroblast cell line (NIH-3T3) 
stably overexpressing constitutively active Src (Src-3T3) were all observed to take 
up rhodamine-123 (Rh-123, Figure 4), a known substrate of OATP1A2. None of 
these cells took up appreciable amounts fluorescein-methotrexate (FMTX) and fluo-
3, substrates of other OATP isoforms (i.e. 1B1 and 1B3). In addition, the uptake of 
Rh-123 by MDA-MB-231, PC3, and LNCaP cells was shown to be protein-mediated 
via a series of drug and temperature inhibition assays. Finally, a primitive inhibition 
assay indicated that the uptake of Rh-123 by LNCaP cells grown in androgen-
depleted conditions was mediated by OATP1A2, which was consistent with a 
previous report.14 Future experiments will explore the localization of OATPs and 
determine the effects of their transported substrates on invadopodia morphology and 
function. If OATPs are found to play a role in the development and/or activity of 
invadopodia, they may serve as viable therapeutic targets. 
 
Figure 4. Chemical structure of rhodamine-123 (Rh-123). Rh-123 was selected 
as the tracer dye for assessing OATP1A2 activity in the current study. The presence 
of the ester group is critical for the robust fluorescence of Rh-123, which is 
remarkably resistant to photobleaching.21 The image was retrieved from the 
ThermoFisher Scientific website. 
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V. Methods 
Cell culture 
 
 The PC3 and LNCaP human prostate carcinoma cell lines were cultured in 
RPMI media (Sigma Aldrich, R8758) containing 10% fetal bovine serum (Sigma 
Aldrich, F0926) supplemented with 100 units/mL penicillin, 100 µg/mL streptomycin 
(Corning, 30-002-Cl), 2 mM L-glutamine, 10 mM HEPES (VWR, VW1481-04), and 1 
mM sodium pyruvate (Thermo Scientific, SH30239.01). Human breast carcinoma 
MDA-MB-231 cells were cultured in RPMI media containing 10% fetal bovine serum 
supplemented with 100 units/mL penicillin and 100 µg/mL streptomycin. Src-
transformed NIH-3T3 cells (murine fibroblasts) were cultured in DMEM (Sigma 
Aldrich, D6429) containing 10% fetal bovine serum supplemented with 100 units/mL 
penicillin and 100 µg/mL streptomycin. All cell lines were cultured at 37°C and 5% 
CO2. 
Fluorescence transport assay: Overview and optimization 
 
 The OATP fluorescent substrate dyes, rhodamine-123 (Rh-123, ICN 
Biomedicals, IC15653025), fluorescein-methotrexate (FMTX, Biotium, 89138-112), 
and fluo-3 pentapotassium salt (Fluo-3, Biotium, 89139-176), were acquired and 
resuspended in DMSO (1 mM stock concentration). An old 1 mM stock of Fluo-3 AM 
(DMSO, Molecular Probes, F1242), a permeant derivative of Fluo-3, was used as 
the positive control. Log phase cells grown in 10-cm dishes were washed with 6 mL 
of phosphate buffered saline (Sigma Aldrich, D8537), lifted with 2 mL of 0.25% 
trypsin-EDTA (Sigma Aldrich, T4049), diluted with 2 mL of media, and counted using 
a hemocytometer. The suspensions were then diluted with an appropriate volume of 
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media, and 4.0-5.0 x 105 cells were seeded into 6-well plates coated with or without 
poly-D-lysine (Sigma-Aldrich, P6407). These cells were incubated for 18 hours at 
37°C. Next, the cells were washed three times with 1.25 mL of pre-warmed HBSS 
buffer (Sigma-Aldrich, H1387) on a 37°C hot plate. Two milliliters of each OATP 
substrate dye solution (in HBSS) were applied to the wells in triplicate. The final 
substrate dye concentrations (i.e. Km values) are provided in Table I along with 
relevant spectroscopic and kinetic data. 
Table I. Spectroscopic and kinetic data for OATP fluorescent substrates. The 
substrate solutions were prepared using the provided Km concentrations. In the case 
of a dye with multiple OATP targets, the average Km concentration was used. 
 
Substrate Dye 
Maximum Wavelength (nm) 
Target(s)10 Km (µM)22,23 Excitation Emission 
Rh-123 506 529 OATP1A2 0.3 
FMTX 496 516 
OATP1B1 5.2 
OATP1B3 8.9 
Fluo-3  506 526 OATP1B3 2.3 
Fluo-3 AM (+) 488 525 Permissible N/A 
 
 After incubating for 30 minutes at 37°C, the cells were washed three times 
with 1.25 mL of 4°C HBSS buffer. To each well, 300 µL of 1M NaOH were added, 
and the cells were manually lysed using a Corning scraper. The plates were again 
covered and incubated at 37°C for 1 hour. The lysates were then neutralized with 50 
µL of 6 M HCl. Bradford assays were performed using 10 µL of each sample to 
determine the respective protein concentrations (Bio-Rad). A calibration curve was 
constructed from triplicate measurements of 1, 2, 3, 4, and 5 µg bovine serum 
albumin (BSA) standards and absorbance at 595 nm was measured using a 
VersaMax plate reader (Molecular Devices, BNR05610). One hundred microliters of 
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each sample were transferred to a black 96-well plate in duplicate or triplicate. 
These samples were excited with 485 nm light and the emission at 535 nm was 
measured using a Tecan Infinite F500 microplate reader. The fluorescence 
intensities were then normalized to protein concentrations. An overview of the initial 
fluorescence transport assay protocol is outlined in Figure 5. 
 
Figure 5. Overview of the initial fluorescence transport assay protocol for 
mammalian cell lines. 
 
 After performing replicate experiments of the aforementioned fluorescence 
transport assay protocol, it became apparent that there was an issue with the 
reproducibility of the results (compare the magnitudes of the normalized Rh-123 
fluorescence signals of MDA-MB-231 in Figures 8 and 11). While the overall trends 
between trials were similar, the magnitudes of the fold normalized fluorescence 
values varied widely. 
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 Due to the drastic reduction in Rh-123 fluorescence intensity above and 
below pH values of 12 and 1, respectively, it was surmised that the strong base lysis 
system may not be appropriate for use with this dye.21,24 In order to reduce the 
possible pH effects on Rh-123 fluorescence, a detergent-based lysis buffer was 
employed. Efficient lysis was achieved with 1% Triton X-100/HBSS and the effect of 
the detergent on Rh-123 fluorescence was determined by creating a dilution curve of 
the dye in both empty and detergent-containing buffers. The presence of 1% Triton 
X-100 reduced Rh-123 fluorescence significantly only at dye concentrations greater 
than 0.5 µM (Figure 6). 
 
Figure 6. Fluorescence transport assay lysis buffer analysis. The presence of 
1% Triton X-100 detergent reduced Rh-123 fluorescence compared to that in empty 
buffer at high dye concentrations. Data are average fluorescence unit values with 
standard deviations from triplicate measurements at each concentration. 
 
 After the lysis buffer was optimized, the protein assay step was omitted. 
Instead of normalizing fluorescence to protein concentration, the fluorescence 
values were inherently normalized to the number of cells plated at the onset of the 
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experiment. This reduced the experimental time and thus improved the efficiency of 
the assay significantly. Furthermore, after completing the time course of Rh-123 
uptake assay (See Figure 10), the incubation step was reduced to 5 minutes. The 
optimized fluorescence transport assay protocol is illustrated in Figure 7. 
Figure 7. Optimized fluorescence transport assay protocol overview. 
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OATP uptake inhibition assays 
 
 Stock solutions of sodium taurocholate (10 mM, dH2O, Alfa, A18346), rifampin 
(10 mM, DMSO, Alfa, J60836), estrone-3-sulfate (12.6 mM, methanol, Sigma, 438-
67-5), and ketoconazole (20 mM, DMSO, MP Pharmaceuticals, 159158) were 
prepared in the indicated solvent. For the PC3 inhibition assays, cells were 
simultaneously exposed to the inhibitor and Rh-123 during the incubation step. 
During the androgen-depleted LNCaP inhibition assay, the cells were incubated with 
the indicated inhibitors for 10 minutes before being exposed to the dye. In addition, 
for the LNCaP assay, the 6-well plates were coated with 50 mg/mL poly-L-lysine for 
one hour and then washed twice with PBS prior to seeding in order to improve cell 
adhesion. The final concentrations of the inhibitors and their OATP targets are 
provided in Table II. 
Table II. List of OATP inhibitors and their relevant targets. 
Inhibitor Targets10,25 Stock Solvent 
Final Concentration 
(mM) 
Sodium 
taurocholate 
OATP1A2, OATP1B1, 
OATP1B3, OAT3 dH2O 0.3 
Rifampin OATP1A2, OATP1B1, OATP1B3 DMSO 0.1 
Estrone-3-
Sulfate 
OATP1A2, OATP1B1, 
OATP1B3, OAPT1C1 Methanol 0.3 
Ketoconazole OATP1A2, OATP1B1, OAT1 DMSO 0.3 
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Androgen receptor stimulation in Src-3T3 cells 
 NIH-3T3 fibroblasts stably expressing constitutively active Src (Src-3T3) were 
grown in either normal media or media containing charcoal-stripped serum for three 
days. Into 12-well dishes, 1.4 x 105 cells of each condition were seeded and 
incubated for 12 hours at 37°C in the appropriate media. When the cells were 
approximately 60-80% confluent, they were challenged with 10 and 100 nM 
solutions of R1881 synthetic androgen receptor agonist (with a final ethanol 
concentration of 0.0001% (v/v) in the appropriate media). The treatments were 
incubated at 37°C for 20 minutes, 1 hour, and 6 hours.  
Fluorescence microscopy 
 Coverslips were washed twice with 1X PBS, fixed with 0.3% 
formaldehyde/PBS for 10 minutes, washed twice more with PBS, and stored at 4°C 
until all slips were processed at once. Next, the slips were permeabilized with 0.1% 
Triton X-100/PBS for 10 minutes with gentle rocking and washed with PBS for five 
minutes three times. The slips were then washed in 0.1% Tween/PBS for 5 minutes 
and inverted on 50 µL drops of an actin stain mixture consisting of 1:200 (v/v) Alexa 
Fluor 488 phalloidin (Molecular Probes, A-12379) and 5% donkey serum in PBS. 
After one hour of incubation at room temperature in the dark, the slips were washed 
three times in PBS and mounted on glass slides using ProLong Gold Plus DAPI (Life 
Technologies, P36935). The slips were left to dry overnight and invadopodia 
morphology was imaged using an Olympus BX51 fluorescent microscope in 
conjunction with QCapture software (version 2.9.13). Images were processed and 
analyzed using ImageJ software (version 1.48).26 
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Data analysis 
 Unless otherwise indicated, all uncertainty values were determined using the 
method of partial derivatives with Maple 2015. The standard deviation of technical 
replicates was used as the uncertainty value of each biological replicate. 
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VI. Results 
OATP fluorescent substrate uptake screen 
 
 In an initial attempt to determine if invadopodia-competent cancer cell lines 
expressed functional OATPs, a series of fluorescence transport assays were 
performed on a variety of cell lines using known fluorescent substrate dyes. The 
uptake of three OATP substrate dyes, rhodamine-123 (Rh-123), fluorescein-
methotrexate (FMTX), and fluo-3 by Src-3T3, PC3, and MDA-MB-231 cell lines was 
assessed using the initial fluorescence transport assay protocol. Robust uptake of 
rhodamine-123 was observed in all three cell lines (Figure 8).  
 
Figure 8. Uptake of OATP substrate dyes by Src-3T3, PC3, and MDA-MB-231 
cell lines. Data are the fold background normalized fluorescence intensities at 535 
nm from a single, representative experiment (n = 1). Each cell line tested took up 
rhodamine-123 (Rh-123), a fluorescent substrate of OATP1A2. Transport of FMTX 
and fluo-3 was significantly lower than that of Rh-123. 
 
 While Rh-123 was shown to accumulate in all cell lines tested, it was unclear 
whether the fluorescence signal of the FMTX and fluo-3 treatments were significantly 
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different from the background (Figure 9). While the acetoxymethyl ester derivative of 
fluo-3 (fluo-3 AM) is a permissible dye that would be expected to easily pass though 
the cell membrane, the stock used in this experiment was old. This could explain the 
low fluorescence intensity of the corresponding cell lysate. In addition, the 
fluorescence transport assay protocol used in this study was not exactly like the one 
published by ThermoFisher Scientific for AM dyes, which could have resulted in 
suboptimal fluorescence intensities.27 
 
Figure 9. Uptake of selected OATP substrate dyes by Src-3T3, PC3, and MDA-
MB-231 cell lines. Data are identical to that in Figure 8 with the Rh-123 treatments 
removed. Further replicates would be required to determine if the signal from the 
FMTX and fluo-3 samples are significantly different from that of the background (n = 
1).  
 
Time course of rhodamine-123 uptake by PC3 cells  
 
  In order to achieve a rough understanding of the kinetics of Rh-123 uptake by 
PC3 cells, a time course experiment was performed using the optimized 
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fluorescence transport assay protocol with incubation times of 2.5, 5, and 10 
minutes. PC3 cells were observed to accumulate Rh-123 most rapidly within the first 
two minutes of incubation, after which the uptake increased at a decreasing rate 
(Figure 10). This trend would be expected for protein-mediated transport as passive 
uptake would be considerably slower.23 
 
Figure 10. Time course of rhodamine-123 uptake by PC3 cells. PC3 cells were 
demonstrated to take up Rh-123 rapidly within the first 5 minutes of incubation. The 
decreasing slope of the curve indicated intracellular Rh-123 may reach its 
equilibrium concentration after 30 minutes. Standard deviations from 3 replicates of 
each time point are shown.  
 
 
OATP inhibition assays 
 
 In order to further determine if the uptake of Rh-123 by MDA-MB-231 cells 
was protein-mediated or a product of simple diffusion, fluorescence transport assays 
were performed at physiological temperature and on ice using the initial protocol with 
a 30 minute incubation period. Since cellular proteins only function properly within a 
narrow temperature range, it was assumed that the cold treatment would reduce 
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transporter activity more than it would affect passive diffusion through the 
phospholipid bilayer. As shown in Figure 11, the cold treatment fluorescence signal 
of the MDA-MB-231 lysate was 67% intense than that of the 37°C treatment. 
 
Figure 11. Effect of temperature on uptake of rhodamine-123 by MDA-MB-231 
cells. Uptake of rhodamine-123 by MDA-MB-231 cells was significantly reduced 
under cold conditions (n = 1). The fluorescence intensity at 535 nm of the cold 
treatment lysate was 67% less than that of the 37°C treatment lysate. 
  
 The results of the time course experiment and initial ice inhibition assay 
indicated that the uptake of Rh-123 by PC3 and MDA-MB-231 cells was protein-
mediated. In order to identify the transporter(s) responsible for this uptake, a series 
of fluorescence transport assays (optimized protocol) were performed in which a 
variety of known OATP inhibitors were introduced in presumably saturating 
quantities during the incubation step. As shown in Figure 12, neither rifampin (0.1 
mM) nor sodium taurocholate (0.3 mM) were shown to inhibit Rh-123 uptake by PC3 
cells at the concentrations used in this experiment. Furthermore, it appeared that 
sodium taurocholate might have actually inhibited dye export as it increased the 
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intracellular Rh-123 concentration. Also shown are the results from an ice inhibition 
assay performed in tandem with the drug inhibitor treatments. The fluorescence 
signal of the ice treatment lysate was 68% lower than that of the 37°C treatment. 
 
Figure 12. Effects of OATP inhibitors on long-term rhodamine-123 uptake by 
PC3 cells. Rh-123 uptake by PC3 cells was not significantly inhibited by rifampin 
(0.1 mM) or sodium taurocholate (0.3 mM) during the 30 minute incubation step at 
37°C. Also shown is the inhibition of Rh-123 uptake by PC3 cells in cold conditions. 
Here the fluorescence signal of the ice treatment lysate was 68% lower than that of 
the 37°C condition. Data are the mean fold background fluorescence intensities and 
standard deviations of three biological replicates for each treatment. Each biological 
replicate value was the mean of three technical replicates (n = 1). 
  
 After considering the results of the time-course assay that indicated an 
import/export equilibrium may have been established after a 30 minute incubation 
step, a series of OATP inhibition assays were performed using an incubation step of 
five minutes (optimized protocol). As shown in Figure 13, rifampin (0.1 mM) and 
taurocholate (0.3 mM) did not inhibit apparent Rh-123 uptake by PC3 cells at this 
time point. Furthermore, the presence of estrone-3-sulfate (E3S) appeared to 
increase the amount of intracellular Rh-123, presumably by inhibiting an exporter. 
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Figure 13. Effects of OATP inhibitors on early rhodamine-123 uptake by PC3 
cells.  Rhodamine-123 uptake by PC3 cells was not significantly inhibited by 
rifampin (0.1 mM), sodium taurocholate (0.3 mM), or estrone-3-sulfate (E3S, 0.3 
mM) when incubated for 5 minutes at 37°C. Conversely, both taurocholate and E3S 
where shown to increase the amount of intracellular Rh-123. Data are the mean fold 
background fluorescence intensities and standard deviations of three biological 
replicates for each treatment. Each biological replicate value was the mean of three 
technical replicates (n = 1).  
 
 To determine if Rh-123 uptake was truly indicative of OATP activity, an 
inhibition assay was performed on LNCaP cells grown in androgen-depleted 
conditions with an additional OATP1A2 inhibitor, ketoconazole. Only the 
ketoconazole (0.3 mM) treatment was shown to significantly inhibit Rh-123 uptake 
by these cells as the fold background fluorescence intensity of the corresponding 
lysate was 50.3% less than that of the Rh-123 only treatment (Figure 14). This result 
potentially validated the optimized fluorescence transport assay protocol used in this 
study as it was consistent with the findings of Arakawa et al.14 
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Figure 14. Effects of OATP inhibitors on early rhodamine-123 uptake by LNCaP 
cells grown in androgen-depleted conditions. Only ketoconazole was shown to 
significantly inhibit Rh-123 uptake by LNCaP cells grown in androgen-depleted 
conditions as the fold background fluorescence intensity of the cell lysate was 50.3% 
less than that of the Rh-123 only treatment. Data are the mean fold background 
fluorescence intensities and standard deviations of three biological replicates for 
each treatment. Each biological replicate value was the mean of three technical 
replicates (n = 1). 
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VII. Discussion 
 Understanding the biological mechanisms responsible for tumor metastasis 
and drug resistance is crucial for designing effective cancer therapies. The work in 
the present study was conducted to establish a project aimed at elucidating the 
potential roles of OATPs in invadopodia-associated tumor metastasis. The first step 
in exploring this query was to determine if OATPs are functionally expressed in a 
variety of invasive cancer cell lines. Before any of the aforementioned experiments 
were carried out, extracted membrane fractions from LNCaP, LNCaP 
overexpressing Tks5 (LNPT), PC3, Src-3T3, and SCC61 (head and neck cancer) 
cells were probed for OAT1 and OATP1B1 via Western Blot. At that time, neither of 
these transporters was detected. In addition, the transporters could not be identified 
in any of these cell lines via immunostaining with the same antibodies. These 
negative results could have stemmed from using un-optimized cell lysis, membrane 
extraction, and immunostaining protocols, which would explain why the positive 
control, caveolin, was also not detected. Alternatively, the protein levels of these 
transporters in cultured cells may simply be below the detection limit of the 
aforementioned antibody-based techniques. Instead of spending time optimizing 
these methods, a series of functional assays were employed. 
 Using fluorescence transport assays, Src-3T3, PC3, LNCaP, and MDA-MB-
231 cell lines were shown to take up Rh-123 dye more effectively than any other dye 
tested. As Rh-123 is a substrate of OATP1A2, these results provided preliminary 
evidence of functional transporter expression.23 In addition, the uptake of Rh-123 by 
the MDA-MB-231 and PC3 cell lines was likely to be mediated by a transporter(s) 
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since significantly less dye entered the cells when the experiment was carried out on 
ice compared to that at physiological temperature. This was interesting since 
previous reports indicated that MDA-MB-231 cells express low levels of OATP1A2 
mRNA.28 Furthermore, OATP1A2 expression was found to be heightened in less-
invasive breast cancer cell lines. This, in conjunction with the fact that initial 
inhibition assays revealed that Rh-123 uptake by PC3 cells was not reduced in the 
presence of presumably saturating quantities of typical OATP1A2, 1B1, and 1B3 
inhibitors, indicated that the uptake may be mediated by other unknown 
transporter(s).  
 The results of the preliminary inhibition experiments called into question the 
validity of the optimized fluorescence transport assay. In order to assess this 
possibility, another OATP1A2 inhibitor, ketoconazole, was acquired and used in a 
single fluorescence transport assay with LNCaP cells grown in androgen-depleted 
conditions.29 Since Arakawa et al. indicated that OATP1A2 was upregulated in these 
conditions, it was hypothesized that OATP1A2-mediated transport would be easier 
to identify in this model system.14 Here, Rh-123 uptake was significantly reduced by 
concentrated ketoconazole as the fluorescence signal of the corresponding lysate 
was 50.3% less than that of the dye-only treatment. While Arakawa et al. did not use 
ketoconazole, the results of our experiment also suggested enhanced OATP1A2 
expression in these cells.14 However, these researchers observed Rh-123 uptake 
was significantly inhibited by estrone-3-sulfate and taurocholate while these 
substances were shown to increase intracellular Rh-123 accumulation in the current 
work.  
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 These conflicting results may arise from the inherent issues associated with 
fluorescence transport assays. First, since OATPs transport a wide variety of 
substances, it is possible that multiple transporters could be responsible for the 
observed Rh-123 uptake. Thus, while Rh-123 uptake is thought to be primarily 
mediated by OATP1A2 in HEK293 MSRII cells, not all of its potential transporters 
have been identified.23 Another potential source of discrepancy arises from specific 
substrate-transporter interactions. Instead of Rh-123, Arakawa et al. used tritium-
labeled DHEAS, which presumably has a different affinity for and clearance rate 
through OATP1A2 than Rh-123.14 This is compounded by the fact that inhibitors 
frequently have different affinities for a given transporter. For example, for 
OATP1A2, estrone-3-sulfate reportedly has a Km of 16 µM, while that of Rh-123 is 
0.3 µM.23,30 The varying affinities and Vmax values of each substrate/transporter 
combination could be responsible for differential uptake efficiencies. While the 
kinetic data are not available for many OATP/inhibitor combinations, the possible 
effects of differential uptake efficiencies on apparent Rh-123 inhibition must be 
considered when establishing causality. It is also important to note that radiolabeled 
substrates are generally more ideal for transport assays than fluorescent ones 
because radiolabeled substrates yield less background signal and higher detection 
sensitivity comparatively. 
 More problems arise when one considers the fact that certain transporters like 
p-glycoprotein (p-gp) both export Rh-123 and are affected by OATP inhibitors.23 For 
example, if p-glycoprotein were competitively inhibited by estrone-3-sulfate, Rh-123 
export would be impeded, which would result in an inflated intracellular 
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concentration. Additionally, certain compounds like rifampin can induce p-gp activity, 
at least in the human intestine.31 These problems associated with transporter-
substrate kinetics could be partially ameliorated by overexpressing OATPs in the 
cells prior to the transport assay, a very common practice. This would accentuate 
the activity of the importer of interest and the results would be less affected by 
endogenous exporter activities. However, given the fact that ketoconazole is known 
to both inhibit OATP1A2 and p-gp, and a 50.3% reduction in fold background 
fluorescence intensity was observed in the present study, it was likely that 
ketoconazole inhibited Rh-123 import more than its export even at endogenous 
expression levels.29,32 Interestingly, ketoconazole is also known to inhibit androgen 
biosynthesis and is used to treat castration-resistant prostate cancer which lends 
support to the putative relationship between OATP1A2-mediated androgen 
precursor transport and androgen resistance.33 Thus, the combination of 
ketoconazole and Rh-123 transport assays may prove to be useful for assessing 
endogenous OATP1A2 activity in prostate cancer cells. 
 While Rh-123 has been used to study p-gp-mediated export, its use as an 
import protein tracer has not been extensively characterized. Historically, Rh-123 
was believed to be membrane-permeable and thus able to enter the cell without the 
need for a protein carrier.23 However, it was determined that passive diffusion is 
minimal and OATP1A2 activity predominates at concentrations below the micelle 
critical limit (2 µM). To reduce the possibility for passive diffusion, the final 
concentration of Rh-123 was chosen to be 0.3 µM in the current work. The time-
course assay, in conjunction with a variety of drug and temperature inhibition 
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experiments, helped validate that the uptake of Rh-123 by PC3, MDA-MB-231, and 
LNCaP cells was indeed protein-mediated. It should also be noted that a previous 
report indicated that Rh-123 uptake by carcinoma cells was generally greater than 
that by the corresponding normal tissue, which potentially supports the idea that 
certain OATPs (specifically OATP1A2) are upregulated in cancer cell lines.34 
 Taken together, the previous results indicated that OATPs may have been 
present in the three cancer cell lines tested in this study. Since Arakawa et al.’s 
results indicated a potential connection between the OATP substrate DHEAS and 
AR activation, an experiment was conducted to determine the effects of AR 
stimulation on invadopodia morphology in Src-3T3 cells.14 However, due to the fact 
that Src-3T3 cells exhibit highly developed, robust invadopodia, the effects of 
androgen receptor stimulation by R1881 were difficult to determine and therefore 
inconclusive. This could also potentially support the results of Zarif et al. that 
activated AR stimulates Src activity.20 In this cell line, which expresses constitutively 
active Src, further Src activation by AR may have less of an effect on invadopodia 
regulation than it would in a cell line with unaltered Src levels. A more ideal model 
system for this experiment might be LNCaP cells overexpressing Tks5 (LNPT), an 
invadopodia promoter, however, at the time of this experiment, there was a problem 
with our stock LNPT viability. LNPT cells have less pronounced invadopodia and 
presumably lower activated Src levels and therefore invadopodia enhancement 
would be more readily apparent. If OATPs are found to contribute to invadopodia 
formation via a Src-AR pathway, they may serve as viable therapeutic targets. 
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VIII. Future Work 
 In the future, inhibition assays will be performed on a variety of cell lines using 
various concentrations of ketoconazole to determine if the observed inhibition of Rh-
123 uptake by LNCaP cells is a dose-dependent phenomenon. Assuming the effects 
of ketoconazole are dose-dependent, more OATP1A2 inhibitors can be purchased 
and employed to confirm that this transporter is responsible for the majority of the 
observed protein-mediated uptake of Rh-123. Once the OATPs (or similar classes of 
transporters) responsible for Rh-123 uptake have been identified, the effects of their 
inhibition and overexpression on invadopodia activity will be determined using 
gelatin degradation assays in conjunction with inhibitors and/or siRNA. An overview 
of this process is described in Figure 15.35  
 
Figure 15. Overview of the gelatin degradation assay protocol. 
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 The localization of OATPs during invadopodia formation may be determined 
by coexpressing these proteins with Src and Tks5, known invadopodia promoters, in 
a variety of cell lines. Immunofluorescence microscopy and immunoblotting will be 
employed to determine the cellular localization and expression of OATPs in 
invadopodia-competent cells respectively. Finally, the roles of OATPs in the 
development of the C. elegans vulva, an interesting in vivo invadopodia model, can 
be explored in future experiments.36 
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IX. Conclusion 
 It is possible that OATPs (or similar drug transporters) are present in the 
invadopodia-competent cancer cells used in the present study since the uptake of 
Rh-123 by MDA-MB-231, PC3, and LNCaP cells was found to be protein-mediated 
using a series of temperature and drug uptake inhibition assays. Furthermore, the 
fact that Rh-123 uptake by LNCaP cells grown in androgen-depleted conditions was 
likely mediated by OATP1A2 potentially validated the fluorescence transport assay 
protocol optimized for mammalian cell lines that was used in this study. Previous 
reports have indicated that OATs (and assumedly OATPs) may be localized to 
invadopodia as both structures are associated with lipid rafts and caveolin-1. In the 
future, a series of inhibition assays will be performed to determine if OATPs 
contribute to invadopodia activity. In addition, the localization and expression of 
OATPs will be determined using fluorescence microscopy and Western blotting 
respectively. If OATPs are found to localize to invadopodia and contribute to both 
the drug-resistant and invasive phenotypes of aggressive cancer cells, they may be 
effective targets for therapy in the future. 
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